MARKET

GNHRF

GNHRF

Arian Resources
EXMKT
0.0001
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.0005
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
--
P/E (TTM)
-0.0045
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GNHRF last week (0908-0912)?
Weekly Report · 09/15 11:48
Weekly Report: what happened at GNHRF last week (0901-0905)?
Weekly Report · 09/08 11:50
Weekly Report: what happened at GNHRF last week (0825-0829)?
Weekly Report · 09/01 11:45
Weekly Report: what happened at GNHRF last week (0818-0822)?
Weekly Report · 08/25 11:58
Weekly Report: what happened at GNHRF last week (0811-0815)?
Weekly Report · 08/18 11:48
Weekly Report: what happened at GNHRF last week (0804-0808)?
Weekly Report · 08/11 11:58
Weekly Report: what happened at GNHRF last week (0728-0801)?
Weekly Report · 08/04 12:00
Weekly Report: what happened at GNHRF last week (0721-0725)?
Weekly Report · 07/28 12:01
More
About GNHRF
Arch Biopartners Inc. is a portfolio-based biotechnology company. The Company is focused on the development of technologies that make a medical or commercial impact. Its technology platforms include AB569, MetaBlok, Arch Inflammation, Borg and MetaMx. AB569 is a drug candidate for treating antibiotic resistant bacterial infections, primarily in the lungs and urinary tract. MetaBlok is a drug candidate targeting sepsis, cancer metastasis and inflammation based diseases. Arch Inflammation is a treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. Arch Inflammation is focused on developing anti-inflammatory small molecules that target proteins in the innate immune system. Borg is a peptide-solid surface Interface for binding of peptides to solid metal and plastic surfaces to inhibit biofilm formation. MetaMx are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. The Company has not generated any revenues.

Webull offers Arch Biopartners Inc stock information, including EXMKT: GNHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNHRF stock methods without spending real money on the virtual paper trading platform.